Drugs such as Ozempic, Rybelsus and Wegovy have made news for their abilities to treat diabetes and encourage weight loss. These drugs, called...
Vous n'êtes pas connecté
FRIDAY, July 12, 2024 -- Three of four patients stop taking semaglutide (Ozempic or Wegovy) two years after being prescribed the glucagon-like peptide-1 receptor agonist (GLP-1 RA) for weight loss, according to new analysis conducted by Prime...
Drugs such as Ozempic, Rybelsus and Wegovy have made news for their abilities to treat diabetes and encourage weight loss. These drugs, called...
MONDAY, Aug. 12, 2024 -- For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent...
MONDAY, Aug. 12, 2024 -- Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a...
FRIDAY, Aug. 23, 2024 -- Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person's odds for heart...
American reality TV star, Kylie Jenner has denied taking Ozempic to lose weight after having her two kids. In a recent interview with British Vogue,...
Viking Therapeutics (VKTX) has developed a best-in-breed GLP-1 drug. The company is poised to gain a large portion of the massive weight loss drug...
NEW YORK, Aug. 19 (Xinhua) -- Ozempic and other GLP-1 drugs were supposed to revolutionize the battle against obesity, but evidence showed big...
Radio: The weight-loss expert is on Newstalk for a discussion of Ozempic and similar drugs. Prof Luke O’Neill, the guest host, needs to push back...
TUESDAY, Aug. 20, 2024 -- Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that...
The majority of cancer patients involved in a landmark Perth clinical trial remain in remission years later after a breakthrough treatment that...